CURRENT AFFAIRS

2022

Please wait while the activity loads.
If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled.

If loading fails, click here to try again

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]

Which COVID-19 vaccine has become the second one in India to get emergency use approval for administration among those aged below 18 years?

A	Sputnik
B	Covishield
C	Corbevax
D	Johnson & Johnson

Explanation:

Detailed explanation-1: -On 3 November 2021, the Technical Advisory Group for Emergency Use Listing listed the Bharat Biotech BBV152 COVAXIN vaccine against COVID-19 for emergency use.

Detailed explanation-2: -The Indian government has recommended that the time interval between the 1st and 2nd dose should be between 12-16 weeks.

Detailed explanation-3: -COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).

Detailed explanation-4: -Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).

Detailed explanation-5: -BE has manufactured 30 crore doses of CORBEVAX and have already supplied nearly 10 crore doses to the Government of India. Currently, over 3 crore doses of CORBEVAX have been administered in children between 12-15 years of age.

There is 1 question to complete.